Bevisning gates dose: the evidence grade sets the ceiling, and the dose decides how much of that ceiling the product reaches. Value = inverse of price-per-trial-dose-day. Community = mean sentiment of external reviews. Säkerhet caps applied after weighting.
This score is our editorial judgment, not a scientific standard. We combine published evidence, dose, price, transparency, and consumer signals into one composite: this is our method, not a peer-reviewed clinical rating. A higher score means a product does better on the factors we weight, not that it is medically proven to work.
The science behind each active ingredient, independent of which brand sells it.
Resveratrol's more bioavailable cousin, mostly used in blends.
The specific product: dose, price, transparency, and what buyers report.
Säkerhet flags, transparency gaps, dosing concerns, and recurring buyer complaints.
All product data is checked against original sources. Prices, doses, and testing status are updated when product pages change. Bevisning grades are reviewed when new human RCTs are published. Read how we verify.
3.8 out of 5 across 1 verified reviews on 2 platforms.
Medium confidenceConsumer sentiment compiled from 2 public sources (Labdoor, Reddit).
3.8/5 · mixed sentiment
Compiled from a Labdoor listing located during manual research; not independently re-verified against the live page at build time. Rating converted from 100-point to 5-point scale.
1 threads discussed · negative sentiment
Compiled from a Reddit r/longevity listing located during manual research; not independently re-verified against the live page at build time.
These are consumer sentiment signals. They do not measure whether the product actually works. See our evidence section for that.
Public sources on this same product, unrelated to NO1GEVITY. NIH DSLD is the US government's registered label database (shown verbatim). SuppCo.com is a separate, unaffiliated commercial site with no partnership or data-sharing arrangement with us. NO1GEVITY scores are computed independently of both.
SuppCo is a separate, unaffiliated supplement-tracking site with no partnership, data-sharing agreement, or business relationship with NO1GEVITY. We are not endorsed by them and they do not endorse us. The two facts below are individually verified against the manufacturer or NSF; the outbound link is provided only so readers can independently cross-check on a third-party site if they want to.
We treat external opinion very differently depending on where it comes from. Tier A is our strongest signal. Tier C is background sentiment only. Tier Rejected is what we excluded, listed openly so you can see what we discarded.
These reviews are aggregated from third-party sources, not written by NO1GEVITY. Each entry shows its source, retrieval date, and whether the source has an affiliate or paid relationship. We do not edit reviews to change their meaning. Disclosure policy.
Our strongest external evidence. Long-form independent reviews, physical-product lab work, and third-party certifications.
ConsumerLab maintains a page covering Elysium, but the substantive test results and ratings sit behind a paid membership wall.
General-category skepticism: longevity supplements as a class lack proof of lifespan extension in humans, and the sector is described as under-regulated.
An independent academic patient-advocacy group assessed NRPT/Basis specifically for ALS use and concluded they could not recommend it for that condition due to a total absence of preclinical ALS models, case reports, or ALS-patient trials, while corroborating the safety data from the Dellinger trial.
Credentialed commentary from clinicians who disclose no paid relationship. Useful as supporting critique but not a substitute for a clinical outcome trial.
Describes Basis as a legitimate, trial-backed, third-party-certified product but poor value relative to competitors on a cost-per-dose basis.
Marketing-quoted press, obviously fabricated aggregate ratings, or heavy-affiliate 'reviews'. Listed openly so you can see what we excluded.
The page is a review of Innerbody's own competing NAD+ supplement, with Basis appearing only in a pricing/dose comparison table, not as an independently tested product.
Very small, inconsistent sample; recent visible feedback centers on subscription billing problems (irregular shipment frequency, difficulty cancelling) rather than product efficacy.
Additional public mentions we located, kept separate from the deep independent reviews above.
Labdoor passed on purity; docked for under-dosing versus 2026 research levels.
Community view: pioneering but out-competed on both price and dose since 2023.
Longevity brands rarely test their exact finished product. We separate what's tested from what's inferred.
The studies that established the trial dose and evidence grade for each active ingredient in this product. Click through to read the original paper.
Not medical advice. We list the strongest claims made by the brand and check each against traceable evidence.
Rules change often. We record when we last verified each row. See the full regulatory timeline →
We list this openly. If a claim isn't backed by a source we can trace, we'd rather flag it than repeat it.
The original NR + pterostilbene combo. Under-dosed by 2026 research standards.
This Elysium Health Basis scores 6.1, making it below the site average. It delivers 250mg of NR (83% of the 300mg trial dose) with grade B evidence (promising human data, not yet comprehensive). At $2.40/day it's among the more expensive options in Combo.
If you are the manufacturer or brand owner of Basis and believe any data on this page is incorrect (wrong dose, wrong ingredient, wrong price, missing certification, outdated status), you can request a correction.
We review every request, verify it against primär sources, and publish any change with a dated note in the version history above. Corrections from brand owners are treated the same as corrections from anyone else: verified before they move.
Request a correction →The next highest-scoring produkter in Combo, same scoring method, same rules.